Indian Health Tech Startup Tap Health Wins Prestigious ATTD Clinical Innovation Award
The award, supported by diabetes and obesity pharma giant Eli Lilly and Company, validates the calibre of Tap Health’s AI-driven chronic care architecture for between doctor visit care on a global stage.
Gurgaon, 16 Dec 2025 – Tap Health, an Indian AI health tech startup, has won the ATTD Clinical Innovation Award at the Asia edition of the Advanced Technologies & Treatment for Diabetes (ATTD) conference in Singapore. The award, supported by diabetes and obesity pharma giant Eli Lilly and Company, recognises technologies delivering measurable, real-world clinical impact.
“The ATTD-ASIA Award validates that India can build world class clinical AI,” said Rahul Maroli, Co-founder and CEO of Tap Health. “Tap Health is pioneering always-on, personalised between-visit chronic care. When AI is clinically grounded and designed for behaviour change, it can scale quality care to millions and reduce the burden on clinicians.”
Tap Health builds autonomous digital therapeutics for chronic conditions, like diabetes and obesity. Early evidence from the platform indicates improvements in glucose monitoring frequency, healthy behaviour engagement, and patient confidence.
Dr. Amit Gupta, Diabetologist and Clinical Advisor at Tap Health, noted: “Most diabetes management happens outside the clinic, in the small decisions patients make every day. Tap Health’s AI delivers practical guidance that supports better daily control and drives long-term behaviour change between doctor visits.”
